Floatz logo

Therapeutic Asset Ratings

223 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Perflutren Lipid Microsphere Intravenous Suspension
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP2/3CCC (52)
Chimeric Antigen Receptor Modified T Cells Infusion
Peripheral T Cell Lymphoma
UNC Lineberger Comprehensive Cancer CenterP2CCC (51)
Hyaluronidase
Diffuse Large B-Cell Lymphoma
UNC Lineberger Comprehensive Cancer CenterP2CCC (51)
Ulixertinib
Melanoma
UNC Lineberger Comprehensive Cancer CenterP2CCC (51)
Entinostat
Invasive Breast Carcinoma
UNC Lineberger Comprehensive Cancer CenterP1CCC (51)
Isatuximab
Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Lipitor
Esophageal Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Lipitor
Lung Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Lisinopril
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Lisinopril
Esophageal Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Lisinopril
Lung Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Olomorasib
Lung Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Trilaciclib
Lung Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Zofran
Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1CCC (48)
Dordaviprone
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer CenterP2CC (47)
Artesunate
Cervical Intraepithelial Neoplasia Grade 2/3
UNC Lineberger Comprehensive Cancer CenterP1CC (47)
Artesunate
Cervical Intraepithelial Neoplasia
UNC Lineberger Comprehensive Cancer CenterP1CC (47)
Calcium folinate pentahydrate
Basal Cell Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1/2CC (47)
Eloxatin
Basal Cell Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1/2CC (47)
FLUOROURACILUM
Basal Cell Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1/2CC (47)
Irinotecan
Basal Cell Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1/2CC (47)
Panobinostat
Basal Cell Neoplasm
UNC Lineberger Comprehensive Cancer CenterP1/2CC (47)
Artesunate
Cervical Cancer
UNC Lineberger Comprehensive Cancer CenterP1CC (46)
Chimeric Antigen Receptor Modified T Cells Infusion
Neoplasms
UNC Lineberger Comprehensive Cancer CenterP1/2CC (46)
Atezolizumab
Carcinosarcoma
UNC Lineberger Comprehensive Cancer CenterP1CC (43)
Showing 101 to 125 of 223 assets
PreviousPage 5 of 9Next